Surface molecule CD229 as a novel target for the diagnosis and treatment of multiple myeloma.
about
Monoclonal antibodies in the treatment of multiple myeloma: current status and future perspectivesCD229 is expressed on the surface of plasma cells carrying an aberrant phenotype and chemotherapy-resistant precursor cells in multiple myeloma.Cancer stem cell vaccine expressing ESAT-6-gpi and IL-21 inhibits melanoma growth and metastasesTargeting of Ly9 (CD229) Disrupts Marginal Zone and B1 B Cell Homeostasis and Antibody ResponsesThe role of natural killer cells in immunity against multiple myeloma.Monoclonal antibodies: potential new therapeutic treatment against multiple myeloma.Immunophenotype of normal vs. myeloma plasma cells: Toward antibody panel specifications for MRD detection in multiple myeloma.Chimeric Antigen Receptor (CAR) therapy for multiple myeloma.ESAT-6-gpi DNA vaccine augmented the specific antitumour efficacy induced by the tumour vaccine B16F10-ESAT-6-gpi/IL-21 in a mouse model.Antitumor efficacy of viable tumor vaccine modified by heterogenetic ESAT-6 antigen and cytokine IL-21 in melanomatous mouse.Novel anti-myeloma immunotherapies targeting the SLAM family of receptors.Standardisation of minimal residual disease in multiple myeloma.Biomarker analysis and clinical relevance of TK1 on the cell membrane of Burkitt's lymphoma and acute lymphoblastic leukemia.Signaling lymphocytic activation molecules Slam and cancers: friends or foes?
P2860
Q26799104-6AB0B9DE-852F-4543-A483-1277584E304AQ35886785-F4D6419D-7D8E-4CB4-ABD0-88F72C203031Q36309496-7ABB4403-F53C-4D94-9A73-4ECB2A67B229Q36447603-A3FA879B-447B-4A8F-A655-6347DF40CBC0Q37994234-2917BCF9-F622-4459-9E51-920F8C8B5898Q38090691-222AF70D-9762-4964-B26A-6CA1FDDADF3CQ38534837-626307C6-D501-418A-868C-39CE09EF84BDQ38704573-6465F98C-D4D0-439B-A7D4-8EB7F2A31E75Q39151226-2C0AE78F-C078-4636-875C-6E6A514F5375Q39369097-8E54A362-7A73-4EF8-8465-F6EDBD3DEED4Q39389614-BD680A15-C7E7-4537-A5E1-DE99AD640EF6Q39410899-5E853060-A63E-4506-93CE-2D420877FF9EQ41355129-3080C088-5C08-488F-A1D0-BFF5B9CDC1B4Q52584346-D5404201-0D72-494A-9108-C13D6C790DB4
P2860
Surface molecule CD229 as a novel target for the diagnosis and treatment of multiple myeloma.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh
2011年學術文章
@zh-hant
name
Surface molecule CD229 as a no ...... treatment of multiple myeloma.
@en
type
label
Surface molecule CD229 as a no ...... treatment of multiple myeloma.
@en
prefLabel
Surface molecule CD229 as a no ...... treatment of multiple myeloma.
@en
P2093
P2860
P1433
P1476
Surface molecule CD229 as a no ...... treatment of multiple myeloma.
@en
P2093
Adam Jadczak
Andreas H Marx
Axel R Zander
Carsten Bokemeyer
Djordje Atanackovic
Henrike Reinhard
Jens Panse
Julia Templin
Katrin Bartels
Nesrine Lajmi
P2860
P304
P356
10.3324/HAEMATOL.2010.036814
P577
2011-05-23T00:00:00Z